ProCE Banner Activity

Our Thoughts on New Notable Results for Endometrial, Ovarian, and Cervical Cancers from ASCO 2021

Conference Coverage
Clinical Thought

Gynecologic oncology experts share their thoughts on notable new data presented at the 2021 ASCO annual meeting for the treatment of endometrial, ovarian, and cervical cancers.

This ClinicalThought is intended for healthcare professionals practicing medicine outside of the United States.

Released: July 08, 2021

Expiration: July 07, 2022

No longer available for credit.

Share

Faculty

Melissa M. Hardesty

Melissa M. Hardesty, MD, MPH

Affiliate Associate Professor
OB/GYN/GYN Oncology
University of Alaska Anchorage
Gynecologic Oncologist and Managing Partner
Alaska Women’s Cancer Care
Anchorage, Alaska

Supporters

This educational activity is supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Melissa M. Hardesty, MD, MPH

Affiliate Associate Professor
OB/GYN/GYN Oncology
University of Alaska Anchorage
Gynecologic Oncologist and Managing Partner
Alaska Women’s Cancer Care
Anchorage, Alaska

Melissa M. Hardesty, MD, MPH, has disclosed that she has received consulting fees and fees for non-CME/CE services from GlaxoSmithKline.